Stericycle, Inc.SRC.LNASDAQ
Loading
| Metric | Q2 2023 | Q4 2023 | Q2 2024 | Q4 2024 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +242.16% | +55.04% | +89.74% | +69.71% | +75.95% |
| Gross Profit Growth | +173.31% | +74.41% | +98.10% | +108.35% | +95.21% |
| EBITDA Growth | +250.65% | +247.36% | +102.68% | +76.40% | +93.77% |
| Operating Income Growth | +294.07% | +93.61% | +137.01% | +103.33% | +101.41% |
| Net Income Growth | +222.47% | +0.00% | -74.03% | +6.91% | +27.94% |
| EPS Growth | +33.18% | +0.00% | -81.63% | -38.91% | -21.00% |
| EPS Diluted Growth | +39.18% | +0.00% | -81.91% | -40.36% | -24.07% |
| Weighted Average Shares Growth | +142.18% | +106.32% | +41.00% | +74.67% | +62.30% |
| Weighted Average Shares Diluted Growth | +131.54% | +106.32% | +43.19% | +79.37% | +68.16% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +83.81% | +103.66% | +241.99% | -62.92% | +745.38% |
| Free Cash Flow Growth | -1839.71% | +407.29% | +0.00% | -184.66% | +0.00% |
| Receivables Growth | +225.23% | +32.18% | +69.96% | +82.43% | +76.11% |
| Inventory Growth | +391.93% | +89.33% | +120.30% | +88.38% | +80.41% |
| Asset Growth | +263.70% | +31.97% | +148.62% | +122.19% | +131.20% |
| Book Value per Share Growth | +57.89% | -39.36% | +12.48% | -9.43% | -4.99% |
| Debt Growth | +237.72% | +1.87% | +160.22% | +144.53% | +173.05% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +104.60% | +55.49% | +63.63% | +115.23% | +88.42% |